Release Date: 27/03/23 15:10 Summary: PDS dated 24 March 2023 Price Sensitive: No Download Document 637.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%